StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.50+0.08 (+2.34%)

Close on Nov 19, 2026Market cap $44.97MP/E –Yield –

Clene free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Clene's free cash flow for the twelve months ending Dec 31, 2025 was -$18.59M. For fiscal 2025 it was -$18.59M. The highest annual figure on record is -$13.49M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.59M–
FY2024Dec 31, 2024-$21.34M–
FY2023Dec 31, 2023-$30.50M–
FY2022Dec 31, 2022-$44.19M–
FY2021Dec 31, 2021-$35.96M–
FY2020Dec 31, 2020-$19.32M–
FY2019Dec 31, 2019-$13.49M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$4.83M–
Q3 FY2025Sep 30, 2025-$4.00M–
Q2 FY2025Jun 30, 2025-$4.74M–
Q1 FY2025Mar 31, 2025-$5.01M–
Q4 FY2024Dec 31, 2024-$4.87M–
Q3 FY2024Sep 30, 2024-$3.02M–
Q2 FY2024Jun 30, 2024-$6.36M–
Q1 FY2024Mar 31, 2024-$7.09M–
Q4 FY2023Dec 31, 2023-$7.22M–
Q3 FY2023Sep 30, 2023-$6.81M–
Q2 FY2023Jun 30, 2023-$6.98M–
Q1 FY2023Mar 31, 2023-$9.50M–
Q2 FY2022Jun 30, 2022-$10.62M–
Q1 FY2022Mar 31, 2022-$14.02M–
Q4 FY2021Dec 31, 2021-$10.28M–
Q3 FY2021Sep 30, 2021-$7.55M–
Q2 FY2021Jun 30, 2021-$8.77M–
Q1 FY2021Mar 31, 2021-$9.36M–
Q4 FY2020Dec 31, 2020-$5.93M–
Q3 FY2020Sep 30, 2020-$7.79M–
Q2 FY2020Jun 30, 2020-$2.32M–
Q1 FY2020Mar 31, 2020-$3.27M–

More Clene figures

See a number that looks wrong?